医疗卫生机构开展研究者发起的临床研究管理办法(征求意见稿)

2020-12-31 中华人民共和国国家卫生健康委员会 国家卫生健康委

关于医疗卫生机构开展研究者发起的

中文标题:

医疗卫生机构开展研究者发起的临床研究管理办法(征求意见稿)

发布日期:

2020-12-31

简要介绍:

关于医疗卫生机构开展研究者发起的临床研究管理办法(征求意见稿)
公开征求意见的公告

为进一步规范临床研究管理,提高临床研究质量,促进临床研究健康发展,提升医疗卫生机构诊断治疗、预防控制疾病的能力,我委起草了《医疗卫生机构开展研究者发起的临床研究管理办法(征求意见稿)》(见附件)。现面向社会公开征求意见,社会公众可通过以下方式反馈意见:

一、电子邮箱:kjsghc@nhc.gov.cn。

二、信函:北京市海淀区知春路14号,国家卫生健康委科教司(邮政编码:100191,并请在信封上注明“医疗卫生机构开展研究者发起的临床研究管理办法征求意见”字样。

三、传真:010-68792231。

意见反馈截止时间为2021年1月30日。

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.docx)] GetToolGuiderByIdResponse(projectId=1, id=a25811c002035335, title=医疗卫生机构开展研究者发起的临床研究管理办法(征求意见稿), enTitle=, guiderFrom=国家卫生健康委, authorId=0, author=, summary=关于医疗卫生机构开展研究者发起的, cover=, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Dec 31 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<section style="color: #333333;"><strong style="color: inherit;">关于医疗卫生机构开展研究者发起的</strong><strong style="color: inherit;">临床研究<a style="color: #2f92ee;" href="https://www.medsci.cn/guideline/list.do?q=%E7%AE%A1%E7%90%86">管理</a>办法(征求意见稿)</strong></section> <section style="color: #333333;"><strong style="color: inherit;">公开征求意见的公告</strong></section> <p style="color: #333333;">为进一步规范临床研究管理,提高临床研究质量,促进临床研究健康发展,提升医疗卫生机构<a style="color: #2f92ee;" href="https://www.medsci.cn/guideline/list.do?q=%E8%AF%8A%E6%96%AD">诊断</a>治疗、<a style="color: #2f92ee;" href="https://www.medsci.cn/guideline/list.do?q=%E9%A2%84%E9%98%B2">预防</a>控制疾病的能力,我委起草了《医疗卫生机构开展研究者发起的临床研究管理办法(征求意见稿)》(见附件)。现面向社会公开征求意见,社会公众可通过以下方式反馈意见:</p> <p style="color: #333333;">一、电子邮箱:kjsghc@nhc.gov.cn。</p> <p style="color: #333333;">二、信函:北京市海淀区知春路14号,国家卫生健康委科教司(邮政编码:100191,并请在信封上注明&ldquo;医疗卫生机构开展研究者发起的临床研究管理办法征求意见&rdquo;字样。</p> <p style="color: #333333;">三、传真:010-68792231。</p> <p style="color: #333333;">意见反馈截止时间为2021年1月30日。</p>, tagList=[TagDto(tagId=1517, tagName=临床研究)], categoryList=[CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=17889, appHits=114, showAppHits=0, pcHits=1433, showPcHits=17771, likes=3, shares=42, comments=9, approvalStatus=1, publishedTime=Thu Dec 31 16:27:26 CST 2020, publishedTimeString=2020-12-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Thu Dec 31 16:27:22 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 19:07:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.docx)])
66.docx
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2090629, encodeId=b3ba209062962, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b3a2017774, createdName=POssible, createdTime=Tue Sep 27 14:08:03 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914117, encodeId=9cd991411e1d, content=希望学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/74484bd722bb48bda636bc5fd392071a/e27d3f2d7f234234b9d9b62753ad3e86.jpg, createdBy=45442953566, createdName=2430085462, createdTime=Wed Jan 06 16:15:20 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913519, encodeId=69f791351922, content=指导性强,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:29:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913275, encodeId=120a9132e5df, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/62b283b94f6d49ceace9b645eefc8434/72efab23a2a24d8ba614e46b19051092.jpg, createdBy=8a9c5449245, createdName=子茵, createdTime=Sun Jan 03 12:05:43 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913247, encodeId=beea91324e3d, content=感谢,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1a5449565, createdName=ms2000001168454641, createdTime=Sun Jan 03 10:44:57 CST 2021, time=2021-01-03, status=1, ipAttribution=)]
    2022-09-27 POssible

    希望能下载

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2090629, encodeId=b3ba209062962, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b3a2017774, createdName=POssible, createdTime=Tue Sep 27 14:08:03 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914117, encodeId=9cd991411e1d, content=希望学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/74484bd722bb48bda636bc5fd392071a/e27d3f2d7f234234b9d9b62753ad3e86.jpg, createdBy=45442953566, createdName=2430085462, createdTime=Wed Jan 06 16:15:20 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913519, encodeId=69f791351922, content=指导性强,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:29:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913275, encodeId=120a9132e5df, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/62b283b94f6d49ceace9b645eefc8434/72efab23a2a24d8ba614e46b19051092.jpg, createdBy=8a9c5449245, createdName=子茵, createdTime=Sun Jan 03 12:05:43 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913247, encodeId=beea91324e3d, content=感谢,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1a5449565, createdName=ms2000001168454641, createdTime=Sun Jan 03 10:44:57 CST 2021, time=2021-01-03, status=1, ipAttribution=)]
    2021-01-06 2430085462

    希望学习下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2090629, encodeId=b3ba209062962, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b3a2017774, createdName=POssible, createdTime=Tue Sep 27 14:08:03 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914117, encodeId=9cd991411e1d, content=希望学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/74484bd722bb48bda636bc5fd392071a/e27d3f2d7f234234b9d9b62753ad3e86.jpg, createdBy=45442953566, createdName=2430085462, createdTime=Wed Jan 06 16:15:20 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913519, encodeId=69f791351922, content=指导性强,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:29:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913275, encodeId=120a9132e5df, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/62b283b94f6d49ceace9b645eefc8434/72efab23a2a24d8ba614e46b19051092.jpg, createdBy=8a9c5449245, createdName=子茵, createdTime=Sun Jan 03 12:05:43 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913247, encodeId=beea91324e3d, content=感谢,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1a5449565, createdName=ms2000001168454641, createdTime=Sun Jan 03 10:44:57 CST 2021, time=2021-01-03, status=1, ipAttribution=)]
    2021-01-04 dajunma

    指导性强,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2090629, encodeId=b3ba209062962, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b3a2017774, createdName=POssible, createdTime=Tue Sep 27 14:08:03 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914117, encodeId=9cd991411e1d, content=希望学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/74484bd722bb48bda636bc5fd392071a/e27d3f2d7f234234b9d9b62753ad3e86.jpg, createdBy=45442953566, createdName=2430085462, createdTime=Wed Jan 06 16:15:20 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913519, encodeId=69f791351922, content=指导性强,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:29:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913275, encodeId=120a9132e5df, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/62b283b94f6d49ceace9b645eefc8434/72efab23a2a24d8ba614e46b19051092.jpg, createdBy=8a9c5449245, createdName=子茵, createdTime=Sun Jan 03 12:05:43 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913247, encodeId=beea91324e3d, content=感谢,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1a5449565, createdName=ms2000001168454641, createdTime=Sun Jan 03 10:44:57 CST 2021, time=2021-01-03, status=1, ipAttribution=)]
    2021-01-03 子茵

    感谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2090629, encodeId=b3ba209062962, content=希望能下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b3a2017774, createdName=POssible, createdTime=Tue Sep 27 14:08:03 CST 2022, time=2022-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914117, encodeId=9cd991411e1d, content=希望学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210106/74484bd722bb48bda636bc5fd392071a/e27d3f2d7f234234b9d9b62753ad3e86.jpg, createdBy=45442953566, createdName=2430085462, createdTime=Wed Jan 06 16:15:20 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913519, encodeId=69f791351922, content=指导性强,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/294dbbdf6b8c42efb140d9e70f3d35e6/85df95e80e0d44b8a95559af8d6adc7c.jpg, createdBy=37b35449803, createdName=dajunma, createdTime=Mon Jan 04 10:29:19 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913275, encodeId=120a9132e5df, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/62b283b94f6d49ceace9b645eefc8434/72efab23a2a24d8ba614e46b19051092.jpg, createdBy=8a9c5449245, createdName=子茵, createdTime=Sun Jan 03 12:05:43 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913247, encodeId=beea91324e3d, content=感谢,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b1a5449565, createdName=ms2000001168454641, createdTime=Sun Jan 03 10:44:57 CST 2021, time=2021-01-03, status=1, ipAttribution=)]
    2021-01-03 ms2000001168454641

    感谢,学习

    0